The telehealth company Hims, which has sold branded and compounded GLP-1s, recently announced plans to offer a cheaper pill form of the GLP-1
What Is Found
On May 2, 2026, The Lancet published a randomized, double-blind, placebo-controlled trial (Klausen et al., Copenhagen University Hospital) testing once-weekly semaglutide 2.4 mg in 108 treatment-seeking adults with moderate to severe alcohol use disorder and comorbid obesity
Its triple receptor activity makes it particularly valuable for mechanistic investigations involving glucose regulation, nutrient utilization, metabolic flexibility, and energy expenditure
When comparing natural GLP-1 supplements, clinical validation sets Supergut apart
However, even small increases in GLP-1 levels achieved by enhanced secretion or slowed degradation can have significant effects on glucose homeostasis, appetite regulation, and gastrointestinal motility